Jakavi

✅ Treats Myelofibrosis
✅ Manages Polycythemia Vera
✅ Reduces Spleen Size
✅ Alleviates Disease Symptoms
✅ Improves Quality of Life

This product is currently out of stock and unavailable.

Jakavimg Tablet is prescribed for treating chronic idiopathic myelofibrosis and Polycythemia vera.

This medication can be taken with or without meals, though maintaining a consistent daily schedule is recommended for optimal results. Your physician will determine the appropriate dosage and frequency based on your specific condition, which may be adjusted periodically. Strict adherence to your doctor’s instructions is crucial, as improper use or overdose may lead to severe adverse effects. While benefits may take weeks or months to become apparent, continue treatment unless directed otherwise by your healthcare provider.

Common side effects include headaches, dizziness, and thrombocytopenia (low platelet count). This medication may decrease blood cell counts, potentially increasing infection risk. Regular monitoring through blood tests is necessary to assess blood cell levels, as well as heart, liver, kidney function, and lipid profiles.

Inform your doctor about any pre-existing liver or kidney conditions or concurrent medications for infections before starting treatment. Many drugs may interact with Jakavimg, so disclose all medications you’re taking. This treatment is contraindicated during pregnancy and breastfeeding. Both male and female patients should use effective contraception throughout therapy to prevent pregnancy.

THERAPEUTIC APPLICATIONS OF JAKAVI TABLET

  • Management of Polycythemia vera
  • Treatment of chronic idiopathic myelofibrosis

THERAPEUTIC ADVANTAGES OF JAKAVI TABLET

For Polycythemia vera

Polycythemia vera, a hematologic malignancy characterized by excessive erythrocyte production, increases thrombosis risk and other serious complications. Jakavimg Tablet inhibits cancer cell proliferation and induces apoptosis (programmed cell death). While clinically effective, this potent medication carries significant toxicity risks that should be carefully weighed with your oncologist. Patients should maintain adequate hydration and abstain from alcohol and tobacco during treatment.

ADVERSE EFFECTS OF JAKAVI TABLET

Most adverse reactions are transient and resolve as your system adapts to the medication. Consult your physician if symptoms persist or cause concern.

Frequently observed reactions with Jakavi

  • Cephalalgia (headache)
  • Vertigo (dizziness)
  • Thrombocytopenia (reduced platelet count)
  • Erythropenia (decreased erythrocyte count)

ADMINISTRATION GUIDELINES

Administer this medication exactly as prescribed, swallowing the tablet whole without chewing, crushing, or breaking. While Jakavimg Tablet can be taken regardless of meals, maintaining a consistent dosing schedule is advisable.

PHARMACOLOGICAL MECHANISM

Jakavimg Tablet functions as an antineoplastic agent by inhibiting the aberrant protein signaling responsible for malignant cell proliferation, thereby arresting or decelerating cancer progression.

Important Notice:

Our objective is to provide medically reviewed, precise, and reliable health information. However, this content should NOT substitute professional medical advice. The information presented serves educational purposes only and may not encompass all potential adverse effects, drug interactions, warnings, or precautions. Always consult your healthcare provider regarding any medical condition or treatment. This resource aims to complement, not replace, the physician-patient relationship.

Strength

5 mg, 20 mg

Quantity

28 Capsule/s, 56 Capsule/s, 84 Capsule/s

Pharma Form

Tablet/s

Manufacturer

Novartis

Treatment

Anti Cancer

Generic Brand

Cisplatin

Reviews

There are no reviews yet

Add a review
Jakavi Jakavi
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot